Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

82.50
+0.04000.05%
Post-market: 83.220.7200+0.87%18:10 EDT
Volume:4.36M
Turnover:359.23M
Market Cap:47.87B
PE:45.08
High:83.04
Open:81.86
Low:81.86
Close:82.46
52wk High:87.89
52wk Low:65.94
Shares:580.30M
Float Shares:574.00M
Volume Ratio:1.01
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.83
EPS(LYR):1.83
ROE:10.35%
ROA:7.65%
PB:4.63
PE(LYR):45.01

Loading ...

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jan 06

Evercore ISI Adjusts PT on Edwards Lifesciences to $94 From $92, Maintains Outperform Rating

MT Newswires Live
·
Jan 06

Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends

Simply Wall St.
·
Jan 04

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 01

BUZZ-Medtech: Clear split between gainers and losers in 2025

Reuters
·
Dec 31, 2025

FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System

Reuters
·
Dec 23, 2025

FDA Approves Edwards Lifesciences' Sapien M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy

THOMSON REUTERS
·
Dec 23, 2025

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 23, 2025

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 20, 2025

Edwards Lifesciences to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 18, 2025

JPMorgan Upgrades Edwards Lifesciences to Overweight From Neutral, Adjusts PT to $100 From $90

MT Newswires Live
·
Dec 18, 2025

Edwards Lifesciences Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Dec 18, 2025

Canaccord Genuity Adjusts PT on Edwards Lifesciences to $87 From $89, Maintains Hold Rating

MT Newswires Live
·
Dec 17, 2025

Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 17, 2025

Baird Trims Price Target on Edwards Lifesciences to $87 From $88, Maintains Neutral Rating

MT Newswires Live
·
Dec 16, 2025

Edwards Lifesciences Is Maintained at Neutral by Baird

Dow Jones
·
Dec 16, 2025

Edwards Lifesciences CVP, JAPAC Daniel J. Lippis Reports Disposal of Common Shares

Reuters
·
Dec 13, 2025

Donald E. Bobo Jr., CVP of Strategy/Corp Development, Sells Edwards Lifesciences Common Shares

Reuters
·
Dec 13, 2025

Director Leslie Stone Heisz Reports Sale of Edwards Lifesciences Common Shares

Reuters
·
Dec 13, 2025

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Dec 13, 2025